Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

DEXTROSE 5% AND SODIUM CHLORIDE 0.45% (DEXTROSE; SODIUM CHLORIDE) | LOERadar

Viewing data from:

DEXTROSE 5% AND SODIUM CHLORIDE 0.45%

ANDA

DEXTROSE; SODIUM CHLORIDE | A211276 | FRESENIUS KABI USA LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER(TE code: AP)

Products (1)

#001 — 5GM/100ML;450MG/100ML

AP

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Sep 15, 2020

No patent or exclusivity listings for this strength.